homeBanner.png
homepage_currentOpenings.png
homeBanner.png

Developing the Next Generation of Personalized Cancer Immunotherapies


SCROLL DOWN

Developing the Next Generation of Personalized Cancer Immunotherapies


 

Gritstone Oncology is a personalized cancer immunotherapy company that is advancing the field of immuno-oncology to fight cancer in patients with the most difficult-to-treat tumors. We develop potent, next-generation, personalized immunotherapies that harness the power of the patient’s own immune system to specifically recognize non-self targets displayed by the tumor (called tumor-specific neoantigens) to effectively destroy tumor cells.

Our unique approach to neoantigen immunotherapy rests on two key pillars – 1) superior identification of tumor-specific neoantigens, using a proprietary deep learning model trained on large scale data generated from human tumors and 2) delivery of these neoantigens to patients in a highly immunogenic context that drives the patient’s immune system to attack and destroy the tumor.

 
homepage_currentOpenings.png

CURRENT OPENINGS


At Gritstone Oncology, we aim to help people with cancer by leveraging genomic insights about the nature of anti-tumor immune responses to develop personalized neoantigen-targeted immunotherapies to fight and eliminate a patient’s cancer.

 

Comprised of an experienced and dynamic group of professionals, Gritstone is committed to building a successful company using our unique, scientifically-rigorous approach based on deep learning. We are looking for qualified, energetic, collaborative individuals who share our vision of advancing the field of immuno-oncology to join our dynamic team.

 

view careers

CURRENT OPENINGS


At Gritstone Oncology, we aim to help people with cancer by leveraging genomic insights about the nature of anti-tumor immune responses to develop personalized neoantigen-targeted immunotherapies to fight and eliminate a patient’s cancer.

 

Comprised of an experienced and dynamic group of professionals, Gritstone is committed to building a successful company using our unique, scientifically-rigorous approach based on deep learning. We are looking for qualified, energetic, collaborative individuals who share our vision of advancing the field of immuno-oncology to join our dynamic team.

 

view careers